United States · 
What does ExSight Ventures invest in?
ExSight Ventures invests most often at Series A (100% of the rounds on record), in sectors such as Biotechnology, Medical Devices and Pharmaceuticals.
ExSight Ventures highlights
- 01
3 rounds on record
- 02
Mostly Series A: 100% of its rounds
What they do
ExSight Ventures (EV) is a returns-oriented, mission-focused life sciences venture capital firm specializing in early-stage investments in innovative ophthalmic diagnostic and treatment solutions.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- BiotechnologyMedical DevicesPharmaceuticals
- Based in
- New York, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first3 appearances
- 2022
1 round
- Nov
- 2019
2 rounds
- Jul
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
JCJames C. MurrayExecutive officer of the managing memberiFiling they signed
We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
7 of 18 we have independently watched raise
A Bell-Shaped DoseCompletes $100MLensgenNovaiONL Therapeutics ClosesQura receives strategicTrefoil Therapeutics Begins2ctechcorpAngelListAutomated Pupillometry UsingCurrent review ofEliosvisionHorizon Surgical SystemsJournalsNovartis acquires DTx PharmaOisRestoring vision lossValitorbio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.